{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:37:46Z","timestamp":1792636666817,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In adults with acute nephrotic syndrome (NS), physical function often declines; however, limited evidence on the efficacy and safety of exercise therapy leads to its avoidance due to fears of exacerbated proteinuria and renal deterioration. This study aimed to assess whether early exercise therapy enhances physical function without elevating risks of non-remission or worsening kidney function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-centre randomised controlled trial enrolled hospitalised adults receiving glucocorticoid therapy for NS. Participants were randomised (1:1) to exercise therapy or standard care. The primary outcome was peak oxygen uptake (peak VO2) at baseline and 6 weeks. The secondary outcome was non-remission at 6 weeks (proteinuria \u22650.3\u2005g\/day). Analyses used multiple imputation for missing data, analysis of covariance adjusted for baseline, and modified Poisson regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-seven participants were recruited (early intervention, n = 13; standard care, n = 14). Peak VO2 increased significantly in the early exercise\u00a0group (\u0394 = 3.45\u2005mL\/kg\/min; 95% confidence interval [CI], 1.22\u20135.67) but not in the standard care group (\u0394 = 1.00\u2005mL\/kg\/min; 95% CI, \u22121.14 to 3.14). Adjusted between-group difference at 6 weeks was 2.46\u2005mL\/kg\/min (95% CI, \u22120.12 to 5.03). Risk ratio for non-remission was 0.673 (95% CI, 0.266\u20131.703), with no significant intergroup difference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early exercise therapy in acute NS improved exercise tolerance clinically, although the primary outcome between-group difference was not statistically significant. No evidence indicated increased non-remission risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>This trial was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) (registration number: UMIN000038250; registration date: October 9, 2019).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/joneph\/aajag129","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:37:18Z","timestamp":1778585838000},"page":"1444-1452","source":"Crossref","is-referenced-by-count":0,"title":["Early exercise therapy for acute nephrotic syndrome: a randomised\u00a0clinical trial"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3310-5701","authenticated-orcid":false,"given":"Yuma","family":"Hirano","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, Hamamatsu University Hospital , 1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka 431-3192 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8143-8845","authenticated-orcid":false,"given":"Tomoyuki","family":"Fujikura","sequence":"additional","affiliation":[{"name":"Internal Medicine 1, Hamamatsu University Hospital , 1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka 431-3192 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Hamamatsu University Hospital , 1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka 431-3192 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Hamamatsu University Hospital , 1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka 431-3192 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hasui","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Hamamatsu University Hospital , 1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka 431-3192 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Takashima","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Hamamatsu University Hospital , 1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka 431-3192 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Deng","sequence":"additional","affiliation":[{"name":"Graduate School of Rehabilitation Medicine, Hamamatsu University School of Medicine , Hamamatsu, Shizuoka 431-3192 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Hamamatsu University Hospital , 1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka 431-3192 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"2026102121374055200_aajag129-B1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s41687-025-00937-7","article-title":"Development of the nephrotic syndrome symptom and impact patient reported outcome (Nephrossi-Pro) measure for use in adults and adolescents with primary glomerulopathies","volume":"9","author":"Maher","year":"2025","journal-title":"J Patient Rep Outcomes"},{"key":"2026102121374055200_aajag129-B2","doi-asserted-by":"publisher","first-page":"124315","DOI":"10.1155\/2013\/124315","article-title":"Quality of life in patients with minimal change nephrotic syndrome","volume":"2013","author":"Shutto","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"2026102121374055200_aajag129-B3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/ckj\/sfz092","article-title":"The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the nephrotic syndrome study network","volume":"13","author":"Troost","year":"2020","journal-title":"Clin Kidney J"},{"key":"2026102121374055200_aajag129-B4","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s00415-025-13482-6","article-title":"Glucocorticoid-induced myopathy: a comprehensive review","volume":"272","author":"G\u00e9fard-Gontier","year":"2025","journal-title":"J Neurol"},{"key":"2026102121374055200_aajag129-B5","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.2011.1556","article-title":"Hospitalization-associated disability: \u201cshe was probably able to ambulate, but I\u2019m not sure\u201d","volume":"306","author":"Covinsky","year":"2011","journal-title":"JAMA"},{"key":"2026102121374055200_aajag129-B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12882-019-1674-6","article-title":"Length of hospital stay is associated with a decline in activities of daily living in hemodialysis patients: a prospective cohort study","volume":"21","author":"Kamitani","year":"2020","journal-title":"BMC Nephrol"},{"key":"2026102121374055200_aajag129-B7","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s40620-024-02049-9","article-title":"Physical activity and exercise in chronic kidney disease: consensus statements from the physical exercise working group of the Italian society of nephrology","volume":"37","author":"Battaglia","year":"2024","journal-title":"J Nephrol"},{"key":"2026102121374055200_aajag129-B8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1298\/ptr.E9939","article-title":"A pilot study to relationship between urinary protein excretion and muscle strengthening in patients with acute onset renal disease","volume":"21","author":"Iwai","year":"2018","journal-title":"Phys Ther Res"},{"key":"2026102121374055200_aajag129-B9","doi-asserted-by":"publisher","first-page":"15628","DOI":"10.36141\/svdld.v42i3.15628","article-title":"Effect of exercise training in patients with cardiac sarcoidosis after induction of oral corticosteroid therapy","volume":"42","author":"Yanagi","year":"2025","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026102121374055200_aajag129-B10","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s00421-021-04697-2","article-title":"Effects of exercise in patients with connective tissue disease receiving high-dose glucocorticoids: a pilot prospective cohort study","volume":"121","author":"Nagashima","year":"2021","journal-title":"Eur J Appl Physiol"},{"key":"2026102121374055200_aajag129-B11","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/nu13051444","article-title":"Renal rehabilitation: exercise intervention and nutritional support in dialysis patients","volume":"13","author":"Hoshino","year":"2021","journal-title":"Nutrients"},{"key":"2026102121374055200_aajag129-B12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.7888\/juoeh.44.257","article-title":"Rehabilitation of a patient with minimal change nephrotic syndrome and acute kidney injury: a case report","volume":"44","author":"Hirano","year":"2022","journal-title":"J UOEH"},{"key":"2026102121374055200_aajag129-B13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s10157-018-1681-0","article-title":"Evaluation of the safety, effectiveness, and health-related QOL impact of early rehabilitation in patients with nephrotic syndrome","volume":"23","author":"Iwai","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"2026102121374055200_aajag129-B14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s13730-021-00649-z","article-title":"Effectiveness and safety of rehabilitation on minimal change nephrotic syndrome in remission for elderly patients with low activity of daily living: a case report","volume":"11","author":"Takahashi","year":"2022","journal-title":"CEN Case Rep"},{"key":"2026102121374055200_aajag129-B15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2165\/00007256-198401020-00003","article-title":"Exercise and renal function","volume":"1","author":"Poortmans","year":"1984","journal-title":"Sports Med"},{"key":"2026102121374055200_aajag129-B16","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/sj.ki.5000410","article-title":"The podocyte's response to injury: role in proteinuria and glomerulosclerosis","volume":"69","author":"Shankland","year":"2006","journal-title":"Kidney Int"},{"key":"2026102121374055200_aajag129-B17","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1111\/j.1523-1755.2004.09220.x","article-title":"Why is proteinuria an ominous biomarker of progressive kidney disease?","volume":"66","author":"Zandi-Nejad","year":"2004","journal-title":"Kidney Int"},{"key":"2026102121374055200_aajag129-B18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1651-2227.1988.tb10644.x","article-title":"Renal function and albumin excretion during exercise in children during remission of the minimal change nephrotic syndrome","volume":"77","author":"Berg","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"2026102121374055200_aajag129-B19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","journal-title":"Kidney Int"},{"key":"2026102121374055200_aajag129-B20","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"Consort 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"2026102121374055200_aajag129-B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13730-017-0280-3","article-title":"Unexpected delayed bleeding after native renal biopsy: a case report","volume":"7","author":"Takeuchi","year":"2018","journal-title":"CEN Case Rep"},{"key":"2026102121374055200_aajag129-B22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s13730-019-00408-1","article-title":"Arteriovenous fistula-related renal bleeding 5 days after percutaneous renal biopsy","volume":"8","author":"Shima","year":"2019","journal-title":"CEN Case Rep"},{"key":"2026102121374055200_aajag129-B23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s41100-019-0209-8","article-title":"Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases","volume":"5","author":"Yamagata","year":"2019","journal-title":"Ren Replace Ther"},{"key":"2026102121374055200_aajag129-B24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1164\/rccm.167.2.211","article-title":"ATS\/ACCP statement on cardiopulmonary exercise testing","volume":"167","author":"American Thoracic Society, American College of Chest Physicians","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026102121374055200_aajag129-B25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/clc.4960130809","article-title":"Metabolic equivalents (mets) in exercise testing, exercise prescription, and evaluation of functional capacity","volume":"13","author":"Jett\u00e9","year":"1990","journal-title":"Clin Cardiol"},{"key":"2026102121374055200_aajag129-B26","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1001\/jama.2009.681","article-title":"Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis","volume":"301","author":"Kodama","year":"2009","journal-title":"JAMA"},{"key":"2026102121374055200_aajag129-B27","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.mayocp.2024.09.023","article-title":"Cardiorespiratory fitness and mortality in patients with chronic kidney disease: a prospective cohort study","volume":"100","author":"Sui","year":"2025","journal-title":"Mayo Clin Proc"},{"key":"2026102121374055200_aajag129-B28","doi-asserted-by":"publisher","first-page":"20220040","DOI":"10.2490\/prm.20220040","article-title":"Effectiveness and safety of rehabilitation for pediatric patients with nephrotic syndrome in the acute phase: a case study","volume":"7","author":"Tabata","year":"2022","journal-title":"Prog Rehabil Med"},{"key":"2026102121374055200_aajag129-B29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10157-021-02119-3","article-title":"Association of initial prednisolone dose with remission, relapse, and infectious complications in adult-onset minimal change disease","volume":"26","author":"Tanabe","year":"2022","journal-title":"Clin Exp Nephrol"},{"key":"2026102121374055200_aajag129-B30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jama.1985.03350260088032","article-title":"Postexercise proteinuria in humans. Facts and mechanisms","volume":"253","author":"Poortmans","year":"1985","journal-title":"JAMA"},{"key":"2026102121374055200_aajag129-B31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.jrn.2007.10.031","article-title":"Renal alterations during exercise","volume":"18","author":"Bellinghieri","year":"2008","journal-title":"J Ren Nutr"},{"key":"2026102121374055200_aajag129-B32","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1152\/japplphysiol.00392.2022","article-title":"Renal blood flow during exercise: understanding its measurement with Doppler ultrasound","volume":"134","author":"Rocha","year":"2023","journal-title":"J Appl Physiol (1985)"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/7\/1444\/70617693\/aajag129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/7\/1444\/70617693\/aajag129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:37:49Z","timestamp":1792633069000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/39\/7\/1444\/8759533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,8,12]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajag129","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,12]]}}}